Legislation impacting pharmacy benefits
Optum Rx closely monitors and acts to influence legislation that has the potential to adversely impact pharmacy benefits offered by both fully insured and self-insured clients.
The most recent updates are available, below. Check back on a quarterly basis for the latest legislative updates.
![](/content/hub5/regulatory-updates/_jcr_content/root/container/container/column_full/col1/column_half/col1/o4_adaptiveimage.jpg)
Regulations to watch: Spring 2024
Optum Rx closely monitors and acts to influence legislation and rulemaking that has the potential to adversely impact pharmacy benefits offered by both fully insured and self-insured clients. Here is a quick summary of the latest pharmacy benefit legislative and regulatory issues happening this winter:
- Federal PBM reform legislation unlikely in federal funding package
- Centers for Medicare and Medicaid Services releases 2025 Advance Notice and guidance on Medicare prescription payment plan
- 2024 State legislative sessions underway
- New York proposes new PBM regulation
- FDA approves Florida drug importation plan
- Supreme Court to consider abortion drug cases
- What Optum Rx is doing and how your voice can be heard
![](/content/dam/o4-dam/images/professionals/pharmacies/woman-sitting-at-computer-1080x720.jpg)
Addressing pharmacy issues that matter to you
![](/content/dam/o4-dam/images/professionals/pharmacies/woman-sitting-outside-on-computer-1080x720.jpg)
Regulatory update: Winter 2023
![](/content/dam/o4-dam/images/professionals/pharmacies/man-woman-looking-at-paper-1080x720.jpg)